Hi all -- I am really struggling with a risk analysis.
We make a stand-alone software device which is used to view echocardiograms. If, for some reason, the software fails and part of the echocardiogram is missing, a physician could potentially plan treatment with missing information. Or if, for some reason, the software fails, corrupting the images, the clinician could plan treatment with incorrect information. Both of these circumstances could, should the physician choose to treat the patient using our device as the sole means of diagnosis, lead to death.
Now, the odds of this happening are improbable. Vanishingly small.
Do I need to account for these in a 14971/62304 risk analysis?
EU and FDA say we are Class IIa and Class II respectively -- but how can this be if death is a possibility? Any cardiological intervention would lead to some sort of injury, most of the requiring medical treatment.
Can someone please clarify?
We make a stand-alone software device which is used to view echocardiograms. If, for some reason, the software fails and part of the echocardiogram is missing, a physician could potentially plan treatment with missing information. Or if, for some reason, the software fails, corrupting the images, the clinician could plan treatment with incorrect information. Both of these circumstances could, should the physician choose to treat the patient using our device as the sole means of diagnosis, lead to death.
Now, the odds of this happening are improbable. Vanishingly small.
Do I need to account for these in a 14971/62304 risk analysis?
EU and FDA say we are Class IIa and Class II respectively -- but how can this be if death is a possibility? Any cardiological intervention would lead to some sort of injury, most of the requiring medical treatment.
Can someone please clarify?
Last edited: